Rath Meera, Müller Ingrid, Kropf Pascale, Closs Ellen I, Munder Markus
Department of Pharmacology, Institute of Medical Sciences, Faculty of Medical Sciences, Siksha 'O' Anusandhan University , Bhubaneshwar , India.
Section of Immunology, Department of Medicine, Imperial College London , London , UK.
Front Immunol. 2014 Oct 27;5:532. doi: 10.3389/fimmu.2014.00532. eCollection 2014.
Macrophages play a major role in the immune system, both as antimicrobial effector cells and as immunoregulatory cells, which induce, suppress or modulate adaptive immune responses. These key aspects of macrophage biology are fundamentally driven by the phenotype of macrophage arginine metabolism that is prevalent in an evolving or ongoing immune response. M1 macrophages express the enzyme nitric oxide synthase, which metabolizes arginine to nitric oxide (NO) and citrulline. NO can be metabolized to further downstream reactive nitrogen species, while citrulline might be reused for efficient NO synthesis via the citrulline-NO cycle. M2 macrophages are characterized by expression of the enzyme arginase, which hydrolyzes arginine to ornithine and urea. The arginase pathway limits arginine availability for NO synthesis and ornithine itself can further feed into the important downstream pathways of polyamine and proline syntheses, which are important for cellular proliferation and tissue repair. M1 versus M2 polarization leads to opposing outcomes of inflammatory reactions, but depending on the context, M1 and M2 macrophages can be both pro- and anti-inflammatory. Notably, M1/M2 macrophage polarization can be driven by microbial infection or innate danger signals without any influence of adaptive immune cells, secondarily driving the T helper (Th)1/Th2 polarization of the evolving adaptive immune response. Since both arginine metabolic pathways cross-inhibit each other on the level of the respective arginine break-down products and Th1 and Th2 lymphocytes can drive or amplify macrophage M1/M2 dichotomy via cytokine activation, this forms the basis of a self-sustaining M1/M2 polarization of the whole immune response. Understanding the arginine metabolism of M1/M2 macrophage phenotypes is therefore central to find new possibilities to manipulate immune responses in infection, autoimmune diseases, chronic inflammatory conditions, and cancer.
巨噬细胞在免疫系统中发挥着重要作用,既是抗菌效应细胞,也是免疫调节细胞,可诱导、抑制或调节适应性免疫反应。巨噬细胞生物学的这些关键方面基本上由巨噬细胞精氨酸代谢的表型驱动,这种表型在不断演变或正在进行的免疫反应中普遍存在。M1巨噬细胞表达一氧化氮合酶,该酶将精氨酸代谢为一氧化氮(NO)和瓜氨酸。NO可进一步代谢为下游活性氮物质,而瓜氨酸可通过瓜氨酸-NO循环重新用于高效的NO合成。M2巨噬细胞的特征是表达精氨酸酶,该酶将精氨酸水解为鸟氨酸和尿素。精氨酸酶途径限制了用于NO合成的精氨酸可用性,而鸟氨酸本身可进一步进入多胺和脯氨酸合成的重要下游途径,这对细胞增殖和组织修复很重要。M1与M2极化导致炎症反应的相反结果,但根据具体情况,M1和M2巨噬细胞均可具有促炎和抗炎作用。值得注意的是,M1/M2巨噬细胞极化可由微生物感染或先天危险信号驱动,而不受适应性免疫细胞的任何影响,继而驱动正在演变的适应性免疫反应的辅助性T(Th)1/Th2极化。由于两种精氨酸代谢途径在各自精氨酸分解产物水平上相互交叉抑制,并且Th1和Th2淋巴细胞可通过细胞因子激活驱动或放大巨噬细胞M1/M2二分法,这构成了整个免疫反应自我维持的M1/M2极化的基础。因此,了解M1/M2巨噬细胞表型的精氨酸代谢对于寻找在感染、自身免疫性疾病、慢性炎症性疾病和癌症中操纵免疫反应的新可能性至关重要。